If the court sides with antiabortion activists and limits or bans the use of mifepristone, the decision could undermine the FDA's authority to regulate all drugs and medical devices, potentially putting people who depend on those products at risk of harm.
Such lawsuits could lead to chaos for doctors and patients and could deter researchers from trying to introduce new medical treatments, Gostin says.
[
add
]
[
|
|
...
]